Literature DB >> 30040778

Assessment for resumed driving in stroke patients via Functional Independence Measure1.

Takuya Inoue1,1, Hideki Ooba2, Masahito Hirano2, Itaru Takehara2, Shu Watanabe3, Masahito Hitosugi1.   

Abstract

BACKGROUND: Some stroke survivors hope to resume driving after hospital discharge. For those who had driven frequently before their stroke, a normal daily life depends on being able to drive.
OBJECTIVE: Our objective was to determine whether Functional Independence Measure (FIM) scores predict patient driving ability, which would make them a suitable index for determining if a stroke patient can resume driving.
METHODS: This was a retrospective study of 71 patients who suffered from stroke. We divided them into three groups based on their driving status after discharge: (1) resumed driving (Driver), (2) wish to resume driving (Wisher), and (3) no wish to resume driving (Non-wisher). We compared total FIM scores and subcategories of FIM scores across groups.
RESULTS: Scores on the Motor-FIM and Cognitive-FIM were highest in the Driver group, followed by the Wisher and Non-wisher groups. Moreover, scores on the 'problem solving' and 'memory' subcategories of the Cognitive-FIM were significantly higher in the Driver group than in the Wisher group.
CONCLUSIONS: The FIM could be a useful assessment tool for determining whether or not stroke patients can resume driving. Moreover, among the Cognitive-FIM sub-categories, problem solving and memory ability might be the scores most relevant for this decision.

Entities:  

Keywords:  Vehicle driving; cognitive function; functional independence measure; stroke

Mesh:

Year:  2018        PMID: 30040778     DOI: 10.3233/WOR-182747

Source DB:  PubMed          Journal:  Work        ISSN: 1051-9815


  1 in total

1.  Cognitive-Communication Predictors of Employment Outcomes 1 and 5 Years Posttraumatic Brain Injury.

Authors:  Therese M O'Neil-Pirozzi; Anthony H Lequerica; Nancy D Chiaravalloti; Shannon B Juengst; Jody K Newman
Journal:  J Head Trauma Rehabil       Date:  2021 May-Jun 01       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.